THREAD Transforms Digital Health Data into Actionable Trial Insights

New platform capabilities help sponsors and CROs standardize participant, device, and operational data from any source to identify risks earlier, automate workflows, and improve decentralized and hybrid trial execution.

CARY, N.C., 09 SEP 2026 – THREAD, a leading no-code technology platform for decentralized clinical trial (DCT) and eCOA solutions, today announced new capabilities that transform fragmented clinical trial data into real-time intelligence and action. By connecting participant interactions, digital health technologies, operational data, and external systems into a single, connected data environment, THREAD enables sponsors to identify emerging risks earlier, improve study execution, and make faster, more informed decisions throughout the clinical trial lifecycle.

As clinical trials with decentralized approaches and complex eCOA continue to evolve, sponsors are managing increasing volumes of data and signals from medical devices, wearables, and integrations with third-party platforms. While these technologies have expanded data collection, they have also created disconnected information that makes it difficult to gain timely operational and clinical insights for research sites and study teams.

THREAD addresses this challenge by creating an intelligence layer that transforms disparate data into meaningful information, helping sponsors and CROs move beyond collecting data to actively managing study performance.

These capabilities deliver three key benefits:

• Greater visibility into study performance through standard and customizable reporting that provides real-time insight into operational trends, participant engagement, and trial progress.
• Reduced operational burden through governed automation that streamlines repetitive tasks while maintaining human oversight, auditability, identity controls, and robust data governance.
• Earlier identification of clinical and operational risks through continuous monitoring, real-time alerts, and targeted interventions that help study teams address issues before they impact timelines or participant outcomes.

"Studies don't suffer from a lack of data, they suffer from a lack of real-time insights to make faster clinical decisions," said Paul Taylor, Chief Product Officer at THREAD. "Our technology platform helps unify data from across the study ecosystem, recognize important signals sooner, and take action before operational issues become delays or risks. The result is a more predictable, efficient, and participant-focused trial."

By effectively processing additional study data from any source, THREAD enables sponsors to reduce operational complexity, improve participant engagement, detect risks earlier, and execute complex global clinical trials with greater confidence.

To learn more about this new feature, request a quick demo: https://discover.threadresearch.com/schedule-demo

##

About THREAD

THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. Through its uniquely combined research technology and scientific consulting services, THREAD helps life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and human-centered.

THREAD has been recognized as a leader by Everest Group in its Decentralized Clinical Trial Product PEAK Matrix® Assessments from 2021 through 2023, is positioned in the Leaders Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment, and is named a Major Contender in Everest Group’s Life Sciences eCOA Products PEAK Matrix® Assessment 2025.

Media Contact

Les Yates
THREAD
media@THREADresearch.com